Glenview Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-167,213
Closed -$6.48M 56
2022
Q3
$6.48M Sell
167,213
-728,183
-81% -$29.2M 0.16% 48
2022
Q2
$33.4M Sell
895,396
-489,233
-35% -$19.9M 0.85% 28
2022
Q1
$61.3M Buy
1,384,629
+285,945
+26% +$12.4M 1.25% 24
2021
Q4
$46.7M Sell
1,098,684
-964,613
-47% -$40.5M 1.01% 31
2021
Q3
$89.5M Sell
2,063,297
-259,719
-11% -$11.5M 1.63% 22
2021
Q2
$99.3M Sell
2,323,016
-874,950
-27% -$36.8M 1.64% 18
2021
Q1
$124M Buy
3,197,966
+495,085
+18% +$18.7M 2.09% 13
2020
Q4
$97.2M Buy
2,702,881
+1,657,829
+159% +$59.8M 2.27% 11
2020
Q3
$39.9M Sell
1,045,052
-1,067,949
-51% -$41.2M 1.25% 19
2020
Q2
$74.2M Sell
2,113,001
-274,858
-12% -$9.9M 2.05% 16
2020
Q1
$77.9M Buy
+2,387,859
New +$93.3M 2.12% 17

Other funds holding BSX